A new addition (addiction) for you. The FDA has approved Qamzova, the first China-developed non-opioid painkiller, offering a potential tool to help reduce fentanyl-related overdose deaths.
Created by Nanjing-based biotech firm Delova, Qamzova is the world’s first long-acting injectable analgesic, providing 24-hour pain relief with a single daily dose. The drug is a high-concentration form of meloxicam, a non-steroidal anti-inflammatory (NSAID) in the same class as ibuprofen and aspirin,
